Katharine Carter
Katharine Carter
Senior lecturer, University of Strathclyde
Verified email at strath.ac.uk
Title
Cited by
Cited by
Year
Both interleukin-4 (IL-4) and IL-4 receptor α signaling contribute to the development of hepatic granulomas with optimal antileishmanial activity
S Stäger, J Alexander, KC Carter, F Brombacher, PM Kaye
Infection and immunity 71 (8), 4804-4807, 2003
1532003
Lipid vesicle size of an oral influenza vaccine delivery vehicle influences the Th1/Th2 bias in the immune response and protection against infection
JFS Mann, E Shakir, KC Carter, AB Mullen, J Alexander, VA Ferro
Vaccine 27 (27), 3643-3649, 2009
1512009
Endogenous IL‐4 is necessary for effective drug therapy against visceral leishmaniasis
J Alexander, KC Carter, N Al‐Fasi, A Satoskar, F Brombacher
European journal of immunology 30 (10), 2935-2943, 2000
1502000
Carbohydrate-based micelle clusters which enhance hydrophobic drug bioavailability by up to 1 order of magnitude
X Qu, VV Khutoryanskiy, A Stewart, S Rahman, ...
Biomacromolecules 7 (12), 3452-3459, 2006
1482006
Neutrophils Contribute to Development of a Protective Immune Response during Onset of Infection with Leishmania donovani
E McFarlane, C Perez, M Charmoy, C Allenbach, KC Carter, J Alexander, ...
Infection and immunity 76 (2), 532-541, 2008
1472008
Toll‐like receptor‐4‐mediated macrophage activation is differentially regulated by progesterone via the glucocorticoid and progesterone receptors
LA Jones, JP Anthony, FL Henriquez, RE Lyons, MB Nickdel, KC Carter, ...
Immunology 125 (1), 59-69, 2008
1152008
Comparison of the efficacies of various formulations of amphotericin B against murine visceral leishmaniasis
AB Mullen, KC Carter, AJ Baillie
Antimicrobial agents and chemotherapy 41 (10), 2089-2092, 1997
1041997
The therapeutic effect of sodium stibogluconate in BALB/c mice infected with Leishmania donovani is organ-dependent
KC Carter, AJ Baillie, J Alexander, TF Dolan
Journal of pharmacy and pharmacology 40 (5), 370-373, 1988
981988
Oral delivery of tetanus toxoid using vesicles containing bile salts (bilosomes) induces significant systemic and mucosal immunity
JFS Mann, HE Scales, E Shakir, J Alexander, KC Carter, AB Mullen, ...
Methods 38 (2), 90-95, 2006
852006
The induction of protective immunity to Leishmania major in the BALB/c mouse by interleukin 4 treatment
KC Carter, G Gallagher, AJ Baillie, J Alexander
European journal of immunology 19 (4), 779-782, 1989
821989
Optimisation of a lipid based oral delivery system containing A/Panama influenza haemagglutinin
JFS Mann, VA Ferro, AB Mullen, L Tetley, M Mullen, KC Carter, ...
Vaccine 22 (19), 2425-2429, 2004
762004
Visceral leishmaniasis: drug carrier system characteristics and the ability to clear parasites from the liver, spleen and bone marrow in Leishmania donovani infected BALB/c mice
KC Carter, TF Dolan, J Alexander, AJ Baillie, C McColgan
Journal of pharmacy and pharmacology 41 (2), 87-91, 1989
761989
An essential role for IL‐13 in maintaining a non‐healing response following Leishmania mexicana infection
J Alexander, F Brombacher, HA McGachy, ANJ McKenzie, W Walker, ...
European journal of immunology 32 (10), 2923-2933, 2002
702002
The In Vivo Susceptibility of Leishmania donovani to Sodium Stibogluconate Is Drug Specific and Can Be Reversed by Inhibiting Glutathione Biosynthesis
KC Carter, S Sundar, C Spickett, OC Pereira, AB Mullen
Antimicrobial agents and chemotherapy 47 (5), 1529-1535, 2003
682003
Resistance of Leishmania donovani to Sodium Stibogluconate Is Related to the Expression of Host and Parasite γ-Glutamylcysteine Synthetase
KC Carter, S Hutchison, FL Henriquez, D Legare, M Ouellette, ...
Antimicrobial agents and chemotherapy 50 (1), 88-95, 2006
632006
Visceral leishmaniasis in the BALB/c mouse: a comparison of the efficacy of a nonionic surfactant formulation of sodium stibogluconate with those of three proprietary …
AB Mullen, AJ Baillie, KC Carter
Antimicrobial agents and chemotherapy 42 (10), 2722-2725, 1998
621998
Peroral amphotericin B polymer nanoparticles lead to comparable or superior in vivo antifungal activity to that of intravenous AmbisomeŽ or Fungizone™
JL Italia, A Sharp, KC Carter, P Warn, MNVR Kumar
PloS one 6 (10), e25744, 2011
612011
Peroral amphotericin B polymer nanoparticles lead to comparable or superior in vivo antifungal activity to that of intravenous AmbisomeŽ or Fungizone™
JL Italia, A Sharp, KC Carter, P Warn, MNVR Kumar
PloS one 6 (10), e25744, 2011
602011
Identification of the benzodiazepines as a new class of antileishmanial agent
RL Clark, KC Carter, AB Mullen, GD Coxon, G Owusu-Dapaah, ...
Bioorganic & medicinal chemistry letters 17 (3), 624-627, 2007
592007
In vitro selection of miltefosine resistance in promastigotes of Leishmania donovani from Nepal: genomic and metabolomic characterization
CD Shaw, J Lonchamp, T Downing, H Imamura, TM Freeman, JA Cotton, ...
Molecular Microbiology 99 (6), 1134-1148, 2016
582016
The system can't perform the operation now. Try again later.
Articles 1–20